Advantages Of Genetic Testing Outweigh Arguments Against Widespread Screening

When genetic researchers successfully cloned the gene in which mutations cause cystic fibrosis, they also triggered a growing debate about under what circumstances and in what setting CF testing should be offered. To understand this debate, one needs some background on the history of carrier testing in the United States, a history with two strikingly different testing experiences, both of which are influencing plans for CF testing. The first experience dates to the early 1970s, when about a d

Written byPhilip Reilly
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

To understand this debate, one needs some background on the history of carrier testing in the United States, a history with two strikingly different testing experiences, both of which are influencing plans for CF testing.

The first experience dates to the early 1970s, when about a dozen states enacted poorly conceived laws that mandated testing blacks for sickle cell trait. The testing programs usually targeted black school children or black couples seeking marriage licenses.

These laws paid little, if any, attention to the importance of providing genetic counseling services, to protecting the privacy of the test results, to the problem of the inadvertent discovery of nonpaternity, and to other sensitive issues. As a result, they drew sharp criticism, which, in turn, helped to stimulate enactment of a federal law that offered matching funds for sickle cell testing programs to those states that embraced voluntarism, respected privacy, and provided counseling.

The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies